Patents
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/2007
07/26/2007WO2007084002A2 Antibiotics and methods for producing them.
07/26/2007WO2007083807A1 Peptide derived from hepatitis c virus
07/26/2007WO2007083806A1 HEPATITIS C VIRUS 2a-DERIVED HLA-A2-RESTRICTED ANTIGEN PEPTIDE
07/26/2007WO2007083112A2 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
07/26/2007WO2007082547A1 Eye tuberculosis treating agent and method for the production and use thereof
07/26/2007WO2007066018A3 Novel peptides and the biological use thereof
07/26/2007WO2007065691A3 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
07/26/2007WO2005084158A3 Polypeptide transduction and fusogenic peptides
07/26/2007US20070173458 Neo-tryptophan
07/26/2007US20070173457 Tau-conotoxin peptides
07/26/2007US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues
07/26/2007US20070172936 Purified active HCV NS2/3 protease
07/26/2007US20070172817 Methods of Producing Antibodies for Diagnostics and Therapeutics
07/26/2007US20070172516 Increasing of the resorption of substances via skin and mucous membranes
07/26/2007US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein
07/26/2007US20070172450 Modulation of immune response and methods based thereon
07/26/2007US20070172428 Multivalent constructs for therapeutic and diagnostic applications
07/26/2007DE102006003443A1 Asparagin-10-substituierte Nonadepsipeptide Asparagine-10-substituted nonadepsipeptides
07/26/2007CA2637315A1 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae
07/25/2007EP1811413A1 Molecular orbit computing device for elongation method
07/25/2007EP1811025A1 Mutated amyloid protein
07/25/2007EP1809667A1 Peptides for use in the treatment of obesity
07/25/2007EP1809657A1 Cyclic nonapeptide amides
07/25/2007EP1809656A2 Cyclosporin alkyne analogues and their pharmaceutical uses
07/25/2007EP1809655A1 Methods for the specific production of lysobactin fragments
07/25/2007EP1809654A1 Heterocyclyl-substituted nonadepsipeptides
07/25/2007EP1809653A1 Substituted nonadepsipeptides
07/25/2007EP1809334A2 Conjugates with enhanced cell uptake activity
07/25/2007EP1042365B1 Compounds and methods for modulating occludin related tissue permeability
07/25/2007CN1328381C GnRH-leukotoxin chimeras
07/25/2007CN1328286C Aglyco products and method of use
07/25/2007CN1328285C Inhibitor of stem cell proliferation and uses thereof
07/25/2007CN1327897C Peptide derivative fusion inhibitors of HIV infection
07/25/2007CN101003567A Undecapeptide and application
07/25/2007CN101003566A Inhibition peptide in domain of polymerase protein of hepatitis b virus, and application
07/25/2007CN101003563A Process for the synthesis of a peptide having a trp residue
07/24/2007US7247703 Anticancer agents; protein complex
07/24/2007US7247615 Nucleic acid encoding peptides which antagonist epitope against prostate specific antigen; anticancer agents
07/24/2007CA2162134C Hepatitis-c virus type 4,5 and 6
07/24/2007CA1341536C Transforming growth factor peptides
07/24/2007CA1341535C Transforming growth factor peptides
07/19/2007WO2007082026A2 Catalytic enantioselective silylations of substrates
07/19/2007WO2007081751A2 Compositions and methods for the treatment of cancer
07/19/2007WO2007081516A2 Tumor activated prodrugs
07/19/2007WO2007079605A2 Template-fixed peptidomimetics with antimicrobial activity
07/19/2007WO2007079597A1 Template - fixed peptidomimetics with antimicrobial activity
07/19/2007WO2007079558A2 Proline-rich peptides, pharmaceutical composition, use of one or more peptides and method of treatment
07/19/2007WO2006078783A3 Htm4 used for cell-cycle regulation through its interaction with kap
07/19/2007US20070167377 Inhibitors of glycinamide ribonucleotide transformylase
07/19/2007US20070167376 Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
07/19/2007US20070167375 HLA (human leukocyte antigen)-A2-restricted cytotoxic T lymphocyte (CTL) epitope derived from the interleukin (IL)-13 receptor (R) alpha 2; Eph family of tyrosine kinase receptors
07/19/2007US20070167357 Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
07/19/2007US20070166352 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent
07/19/2007CA2637377A1 Template-fixed peptidomimetics with antimicrobial activity
07/18/2007EP1808184A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman
07/18/2007CN1326882C Carcino-embryonic untigen specific combined peptide and fusion protein with TNF-alpha
07/18/2007CN1326872C Method for preparing echinocandin derivatives
07/18/2007CN100999547A Protein polypeptide of anti new vasoformation and application thereof
07/18/2007CN100999546A Polypeptide compound with aza-containing heterocyclic modified and its application
07/17/2007US7244721 Peptides as NS3-serine protease inhibitors of hepatitis C virus
07/17/2007US7244718 Derivatives of water insoluble drugs which exhibit good activity and water solubility; producing an anesthetic effect in a dog
07/17/2007US7244705 Polyacid glycopeptide derivatives
07/17/2007US7244701 For use in therapy and prophylaxis of hyponatremia, congestive heart failure, liver cirrhosis, nephrotic syndrome and hypertension
07/17/2007US7244437 Clostridial toxin derivatives and methods for treating pain
07/17/2007US7244436 Clostridial toxin derivatives and methods for treating pain
07/17/2007CA2494338C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
07/17/2007CA2162250C Methods of typing hepatitis c virus and reagents for use therein
07/12/2007WO2007078633A2 Bacteriocin inducer peptides
07/12/2007WO2007077278A1 Non-proteolysable oligopeptides that inhibit glycoprotein gp41 of the aids virus
07/12/2007WO2007077112A1 Methods for the synthesis of arginine-containing peptides
07/12/2007WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections
07/12/2007WO2006096800A8 Immunogenic t cell targets in autoimmune hepatitis and methods of use
07/12/2007WO2005019409A3 Combinatorial protein library screening by periplasmic expression
07/12/2007US20070161807 Method for manufacturing optically pure coumaryl amino acids and the novel coumaryl aminoacids thus obtained
07/12/2007US20070161789 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/12/2007US20070161692 Conformationally restricted polyamine analogs as disease therapies
07/12/2007US20070161569 Conformationally constrained parathyroid hormones with alpha-helix stabilizers
07/12/2007US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia
07/12/2007US20070160630 Hepatitis-c virus 4, 5 and 6
07/12/2007US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
07/12/2007US20070160536 prodrug comprising 8-O-(12[L-leucinoylamino]dodecanoyl)-8-O-debutanoylthapsigargin (L12ADT); and a peptide of sequence Ser-Ser-Lys-Tyr-Gln; peptide is linked to the L12ADT to inhibit the therapeutic activity of the drug; anticarcinogenic agent; benign prostate hyperplasia; prostate and breast cancer
07/12/2007US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands
07/12/2007US20070160532 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide
07/12/2007DE4208258B4 Verfahren zur Herstellung von kristallinem Ciclosporin in kugelartiger Teilchenform und seine Verwendung, insbesondere zur pulmonalen Verabreichung A process for producing crystalline Ciclosporin in spheroidal particulate form and to its use, in particular for pulmonary administration
07/12/2007CA2632826A1 Bacteriocin inducer peptides
07/11/2007EP1806357A1 Hypoxia inducible factor-1 and method of use
07/11/2007EP1805210A1 Novel peptides and methods for the treatment of inflammatory disease
07/11/2007EP1805203A2 On-resin peptide cyclization
07/11/2007EP1804823A2 Novel cyclosporin analogues and their pharmaceutical uses
07/11/2007EP1535065A4 Neuroprotective synergy of erythropoietin and insulin-like growth factor
07/11/2007EP1455808B1 Phosphinate-peptide analogues as inhibitors of procollagen-c-proteinase (pcp) for treating fibrotic diseases
07/11/2007EP1404877A4 New assays for preimplantation factor and preimplantation factor peptides
07/11/2007EP1171576B1 Pseudomycin production by pseudomonas syringae
07/11/2007CN1997671A Peptide purification by means of hard metal ion affinity chromatography
07/11/2007CN1997662A Inhibitors based on fusion, HR1 and HR2 sequences in bacterial adhesin
07/11/2007CN1997660A Myosin light chain kinase inhibitors and methods of use
07/11/2007CN1325118C Ion composite type water-soluble pharmaceutical compositions, and use thereof
07/10/2007US7243031 based on open reading frames of oligopeptides; proteomics and artifical proteins; in vitro translation; computer programs
07/10/2007US7241866 Using amines or amino acids as mobile phase modifiers in chromatography
07/10/2007US7241861 High density lipoprotein-reactive peptides